Buffalo colostrum source active peptide modified milk and preparation method of buffalo colostrum source active peptide fermented milk

Through the screening and fermentation technology of buffalo colostrum whey proteolytic base material, buffalo colostrum milk-derived active peptide with high immune activity and antioxidant properties was prepared, which solved the scarcity and bioactive degradation of buffalo colostrum immunoreactive peptide products. The problem of this has achieved stability and functional improvement in the gastrointestinal tract.

CN118909039APending Publication Date: 2024-11-08GUANGXI ZHUANG AUTONOMOUS REGION BUFFALO INST +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410995836.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In the prior art, there are fewer products of colostrum-derived immunoactive peptides, and the biological activity in the gastrointestinal tract is easily degraded after being prepared into food, and it cannot effectively exert its physiological function, and there is a lack of research on gastrointestinal tolerance.

Method used

By preparing the proteolytic base of colostrum whey, using neutral protease enzymatic, peptides with immunostimulation and immunomodulatory activities were screened, and peptides with high antioxidant were prepared in combination with fermentation technology. and immunoactive buffalo colostrum milk-derived active peptide.

Benefits of technology

It improves the immune activity and antioxidant properties of the milk-borne active peptide of buffalo colostrum, enhances its stability and biological activity in the gastrointestinal tract, and expands its application potential in food.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909039A_ABST
    Figure CN118909039A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of enzymic preparation application, in particular to a preparation method of buffalo colostrum source active peptide modified milk and fermented milk, and relates to a method for researching production of buffalo colostrum whey protein enzymolysis base material from buffalo colostrum by utilizing a single factor and response surface analysis method. The buffalo colostrum source whey protein enzymolysis base material with high ABTS free radical scavenging rate is obtained, and a basis is provided for the whole process research; on the basis of four samples, namely BW (buffalo colostrum whey protein), BWH (buffalo colostrum whey protein enzymatic hydrolysis base material), BW-H (buffalo colostrum whey protein-digestion product) and BWH-H (buffalo colostrum whey protein enzymatic hydrolysis base material-digestion product), research of polypeptiomics and bioinformatics is carried out to obtain several immune peptides with the highest expression quantity; the immune peptides are added into a buffalo colostrum whey protein enzymolysis base material, so that the antioxidant activity and immunocompetence of prepared buffalo milk and fermented buffalo milk are effectively improved.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The invention relates to the technical field of enzyme preparation application, and in particular to a method for preparing buffalo colostrum-derived active peptide modulated milk and fermented milk. [Background technology]

[0002] Buffalo milk is the second largest milk in the world, accounting for about 13% of the global milk production, and China is a major producer of buffalo milk. Compared with the milk of other mammals, the protein content of buffalo milk in my country is as high as 4.3%, and buffalo colostrum even reaches 10%. Whey protein is one of the main products of the dairy industry, accounting for about 80% of buffalo colostrum, but the proportion will decrease as the lactation time increases.

[0003] Milk-derived active peptides are specific protein fragments derived from milk proteins, consisting of 2-50 amino acid sequences and having different physiological functions. They are considered to be ideal substances for use in health products or functional foods due to their high specificity, low toxicity, high structural diversity and low molecular weight. Milk proteins contain many peptide sequences with different biological activities, but these bioactive peptides can only play their role after being released through some means. There are three main methods for obtaining bioactive peptides from milk proteins: fermentation, using microorganisms to ferment milk-derived proteins; enzymatic hydrolysis, using endogenous and exogenous proteases to hydrolyze milk proteins; and biosynthesis, based on the sequence of bioactive peptides.

[0004] At present, most products containing buffalo colostrum on the market are milk powder. In recent years, the series of bovine colostrum products have been upgraded and iterated, and products developed for bovine colostrum protein peptides have also appeared, but most of them are solid products. This is because solid products are easy to preserve, not easy to inactivate, and have little effect. Dairy-derived bioactive peptides are highly active, easy to prepare, widely available, and naturally safe, and have attracted widespread attention. In the past few decades, different preparation technologies and methods have been used to continuously discover bioactive peptides with new functions from milk proteins. At the same time, with the rapid development of omics technology, proteomics technology based on biomass spectrometry has also been gradually applied to the study of milk-derived bioactive peptides, making the study of milk-derived bioactive peptides more in-depth. However, too many of the peptide-containing buffalo dairy products studied in the current technology are antioxidant peptides, and buffalo colostrum-derived immune active peptide products are rarely reported. There is also no research on gastrointestinal tolerance and other aspects; when bioactive peptides are used as functional peptides after being made into food, they need to reach the site of action to play a role in the body in order to play their physiological role. Due to the action of digestive enzymes in the digestive tract, the biological properties of protein hydrolysates may remain normal, decrease, or increase. The internal environment of the human gastrointestinal tract is complex, and active peptides are easily affected by various enzymes such as pepsin and trypsin, resulting in degradation, thus losing their biological activity and failing to achieve ideal functions. Therefore, it is necessary to study the active peptides from buffalo colostrum after gastrointestinal digestion, so that the peptides have high immune activity and high gastrointestinal resistance, providing a wider application space for peptide foods. [Summary of the invention]

[0005] In view of the above, it is necessary to study the active peptides derived from buffalo colostrum after gastrointestinal digestion, so that the peptides have high immune activity and high gastrointestinal resistance, providing a wider application space for peptide foods.

[0006] In order to achieve the above object, the technical solution adopted by the present invention is:

[0007] A buffalo colostrum milk-derived active peptide, the amino acid sequence of the milk-derived active peptide is shown as SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4 and / or SEQ ID NO.5.

[0008] The present invention also includes a method for preparing the buffalo colostrum milk-derived active peptide, the method comprising the following steps:

[0009] (1) Preparation of buffalo colostrum whey protein (BW), preparation of buffalo colostrum whey protein enzymatic hydrolysis base (BWH), preparation of buffalo colostrum whey protein-digestion product (BW-H) and buffalo colostrum whey protein enzymatic hydrolysis base-digestion product (BWH-H)

[0010] (2) Peptide extraction: add appropriate amount of acetic acid to the BW, BWH, BW-H and BWH-H samples of step (1), shake well to mix, and centrifuge at high speed; take the supernatant peptide extract, freeze-dry, add TFA to dissolve, pass through a 10K ultrafiltration tube, wash twice with 0.1% TFA, and desalt the filtrate using C18 StageTip and dry under vacuum;

[0011] (3) After drying, the peptide was re-dissolved with TFA and OD 260 Determine peptide concentrations and perform LC-MS / MS analysis;

[0012] (4) Using mass spectrometry database retrieval software and protein database for retrieval analysis, and using the online website BIOPEP to predict potential bioactive peptides for the detected peptides, and screening out peptides with immunostimulatory and immunoregulatory properties; using the online website PeptideRanker to detect the biological activity of the peptides, where an activity score greater than 0.5 is considered to have biological activity, and the top 10 peptides with the highest expression and a PR value greater than 0.5 are selected; and the screened peptides are pasted to the ToxinPred, Innovagen, and AllergenFP websites respectively to predict toxicity, solubility, and sensitization to obtain the milk-derived active peptides.

[0013] The present invention also includes applying the buffalo colostrum milk-derived active peptide, and the method comprises the following steps:

[0014] (1) Preparing a whey protein active peptide base material: adjusting the pH value of buffalo colostrum and centrifuging it to remove the upper fat layer and the lower precipitate to obtain a buffalo colostrum whey protein solution; adjusting the pH value of the buffalo colostrum whey protein solution to 7.5, adding an enzyme for enzymolysis to obtain an enzymolysis solution; centrifuging the enzymolysis solution, taking the supernatant, adjusting the pH to neutral, and then adding the buffalo colostrum milk-derived active peptide to obtain the corresponding buffalo colostrum milk-derived active peptide base material;

[0015] (2) preparing raw buffalo skim milk: taking raw buffalo milk as raw milk, and then performing a skim treatment to obtain skim milk;

[0016] (3) Preparing modulated buffalo milk: mixing the whey protein active peptide base obtained in step (1) with the defatted buffalo milk obtained in step (2), and uniformly mixing the resulting mixture with white sugar and α-cyclodextrin, followed by sterilization to obtain modulated buffalo milk.

[0017] The present invention also includes applying the buffalo colostrum milk-derived active peptide, and the method comprises the following steps:

[0018] (1) preparing a whey protein active peptide base material: enzymatically hydrolyzing buffalo colostrum, centrifuging, taking the supernatant, adjusting the pH to neutral, and then adding the buffalo colostrum milk-derived active peptide to obtain the corresponding buffalo colostrum milk-derived active peptide base material;

[0019] (2) Preparing fermented buffalo milk: taking raw buffalo milk as raw milk, and then skimming it to obtain skimmed milk, controlling the protein content of the skimmed milk to be ≥4.0 g / 100 g; mixing the obtained skimmed buffalo milk with the whey protein peptide base material obtained in the above step (1) and white sugar, and then sterilizing it, and then adding fermentation bacteria to the mixture, and fermenting it at a constant temperature of 39 to 43° C., stopping the fermentation when the fermented milk slightly precipitates whey, and post-ripening it at 4° C. for 24 hours to obtain the fermented buffalo milk.

[0020] Furthermore, the enzyme used for enzymolysis in step (1) is neutral protease, the enzyme addition amount is 6299 U / g, the pH value is 7.5, the enzymolysis time is 2.0 h, and the enzyme activity is 50 U / mg.

[0021] The present invention has the following beneficial effects:

[0022] 1. The present invention utilizes the method of single factor and response surface analysis to study the production of buffalo colostrum and buffalo colostrum whey protein hydrolysis base material, and obtains the buffalo colostrum source whey protein hydrolysis base material with high ABTS free radical scavenging rate, which provides a basis for the entire process research. After optimization, it is obtained that the optimal enzymolysis conditions of buffalo colostrum are enzyme addition amount 6299U / g, pH value 7.5, enzymolysis time 2.0h, enzyme activity 50U / mg, and neutral protease is preferably used.

[0023] 2. This application is based on four samples, namely BW (buffalo colostrum whey protein), BWH (buffalo colostrum whey protein hydrolysate base), BW-H (buffalo colostrum whey protein-digestion product) and BWH-H (buffalo colostrum whey protein hydrolysate base-digestion product), and conducted peptidomics and bioinformatics research to obtain several immune peptides with the highest expression levels. These immune peptides were added to the buffalo colostrum whey protein hydrolysate base, which effectively improved the antioxidant activity and immune activity of modulated buffalo milk and fermented buffalo milk.

Brief Description of the Drawings

[0024] Figure 1 This is the effect of BWH obtained by different types of enzymes on the scavenging rate of ABTS free radicals;

[0025] Figure 2-Figure 5 The effect of BWH obtained at different pH, enzymatic hydrolysis temperature, enzymatic hydrolysis time, and enzyme addition amount on the scavenging rate of ABTS free radicals; pH is Figure 2 The enzymatic hydrolysis temperature is Figure 3 , enzymatic hydrolysis time is Figure 4 , enzyme addition amount is Figure 5 ;

[0026] Figure 6-Figure 8 The figure shows the effect of pH and enzymatic hydrolysis time, pH and enzyme addition amount, and the interaction of enzymatic hydrolysis time and enzyme addition amount on the scavenging rate of ABTS free radicals; Figure 6 pH and enzymatic hydrolysis time, Figure 7 pH and enzyme addition amount, Figure 8 is the enzymolysis time and the amount of enzyme added, among which, ① is the response surface diagram and ② is the contour diagram.

[0027] Fig. 9 The Venn diagram of the identification results of the four groups of samples: BWH, BW, BWH-H, and BW-H;

[0028] Fig.10 The peptide length distribution diagrams of four groups are BWH, BW, BWH-H, and BW-H; ① is BWH, ② is BW, ③ is BWH-H, and ④ is BW-H;

[0029] Fig.11 This is the heat map of cluster analysis of differentially active peptides before and after BWH enzymatic hydrolysis and digestion;

[0030] Figure 12-14 The violin plot (A), correlation bubble plot (B) and PCA score plot (C) of BWH expression distribution before and after enzymatic hydrolysis and digestion; Fig.12 For violin picture; Fig.13 For bubble chart; Fig.14 is the PCA graph;

[0031] Figure 15-17 It is the GO function enrichment bubble diagram of BWH and BW, BWH and BWH-H, and BW and BW-H; among them, Fig.15 For BWH and BW, Fig.16 For BWH and BWH-H, Fig.17 for BW and BW-H;

[0032] Figure 18-Figure 20 This is the KEGG pathway enrichment bar graph of BWH and BW, BWH and BWH-H, and BW and BW-H; among them, Fig.18 For BWH and BW, Fig.19 For BWH and BWH-H, Fig. 20 for BW and BW-H;

[0033] Figure 21-23 It is the protein interaction network diagram between BWH and BW, BWH and BWH-H, and BW and BW-H; among them, Fig.21 For BWH and BW, Fig. 22 For BWH and BWH-H, Fig.23 for BW and BW-H;

[0034] Fig.24 Pie chart of the content of biologically active PR value > 0.5 in BWH. [Specific implementation method]

[0035] In order to make the above-mentioned purpose, features and advantages of the present invention more obvious and easy to understand, the specific implementation of the present invention is described in detail below. In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present invention, so the present invention is not limited by the specific implementation disclosed below.

[0036] Embodiment 1:

[0037] This embodiment is a preparation process of buffalo colostrum whey protein:

[0038] 1. Preparation of buffalo colostrum whey protein: colostrum within 1 to 3 days after calving is collected from a buffalo farm, 1M HCl solution is added to the colostrum to adjust the pH to 4.6, and centrifuged at 8000r / min and 4°C for 20min to discard casein, fat and debris, and the supernatant (whey protein solution) is adjusted to pH 7.0 with 1M NaOH solution. After collection, it is mixed and packaged under low temperature conditions (packaged according to the amount measured each time), and stored at -20°C for later use.

[0039] 2. Screening of the most suitable hydrolase preparation for milk samples: Five endogenous and exogenous proteases, pepsin, trypsin, neutral protease, alkaline protease and papain, were selected to perform single enzyme hydrolysis of buffalo colostrum whey protein for 1.0 h according to the optimal temperature, pH and enzyme dosage provided by the supplier. The protease with the highest clearance rate was screened out with the ABTS free radical scavenging rate as the index, and the optimal BWH sample was prepared under this condition, which was used as the basic material for subsequent research.

[0040] 3. Single factor test: After determining the optimal solution of the protease, the three factors affecting the protease hydrolysis, pH value (6.0, 6.5, 7.0, 7.5, 8.0), enzymatic hydrolysis time (1.0, 2.0, 3.0, 4.0, 5.0h), and enzyme addition amount (3000, 4000, 5000, 6000, 7000U / g) were tested. The ABTS free radical scavenging rate of the enzymatic hydrolyzate was used as an indicator of the optimal hydrolysis conditions.

[0041] 4. Response surface optimization: Based on the single factor experiment, with the ABTS free radical scavenging rate as the metric, three factors, namely, enzymatic hydrolysis pH, enzyme addition amount and time, were selected, and a three-factor three-level response surface experiment was conducted. The optimal protease was used to optimize the enzymatic hydrolysis conditions. According to the results of the single factor experiment, the Box-Behnken design experiment was used to analyze the effects of these three factors on the ABTS free radical scavenging rate. A total of 17 experiments were conducted, including 12 factorial partial experiments and 5 center point repeated experiments. Finally, the optimal BWH extraction process was determined.

[0042] The response surface factors and levels are shown in Table 1.

[0043] Table 1. Response surface test level table

[0044]

[0045] 5. Determination of ABTS free radical scavenging rate: Dilute the ABTS stock solution 400 times to ensure that its OD value is between 0.6 and 0.7 at 405nm, with 0.7 being the optimal value. The enzymatic base material should be diluted 10 times. Add 50mL of diluted enzymatic base material and 200mL of ABTS working solution to a 96-well plate. Replace the enzymatic base material with water as a blank control. After stirring the mixture evenly, react in a dark place at 37℃ for 30 minutes. Finally, measure the OD value at a wavelength of 405nm, and calculate the ABTS free radical scavenging rate according to the following formula:

[0046]

[0047] In the ABTS free radical scavenging rate formula, A blank is the OD value of the blank control at 405 nm; A sample is the OD value of the enzymatic hydrolyzate at 405 nm.

[0048] 6. Statistical analysis of data: The collected test data were expressed as mean ± standard deviation. Each part of the test was carried out in parallel three times. Statistical and analytical software such as Excel and Design-Expert11 were used for data analysis.

[0049] The experimental results are as follows:

[0050] 1. The screening results of the most suitable hydrolase for buffalo colostrum whey protein are as follows Figure 1 As shown in the figure, it can be seen that the neutral protease group has the highest ABTS free radical scavenging rate, which is 86.16%. Therefore, this neutral protease was selected for the next step of the experiment.

[0051] 2. Single factor test results Figure 2-Figure 5 As shown by Figure 2It can be seen that when pH = 7.0, the ABTS free radical scavenging rate is the highest. Therefore, the pH of the enzymatic solution is selected to be 7.0; Figure 3 It can be seen that the removal rate of ABTS by the sample reaches the highest value at about 50℃, so 50℃ is selected as the optimal reaction temperature of neutral protease; Figure 4 It can be seen that when the enzymatic hydrolysis time is about 3.0h, the ABTS free radical scavenging rate is close to the maximum value, so 3.0 is selected as the optimal enzymatic hydrolysis time; Figure 5 It can be seen that when the enzyme addition amount is 6000U / g, the ABTS free radical scavenging rate is the highest.

[0052] 3. Response surface analysis:

[0053] According to the Box-Behnken response surface design principle, combined with the above test results, the three influencing factors of enzymatic hydrolysis pH (6.5, 7.0, 7.5), enzymatic hydrolysis time (2.0h, 3.0h, 4.0h), and enzyme addition (5000U / g, 6000U / g, 7000U / g) were selected, and each factor took 3 levels. The three-factor three-level response surface analysis method was used to optimize the hydrolysis conditions. After the obtained enzymatic hydrolysis base was diluted 10 times, the ABTS free radical scavenging rate was detected. The experimental design and results are shown in Table 2.

[0054] Table 2 Response surface experimental design and results

[0055]

[0056] Design Expert-11 software was used to perform variance analysis on the experimental results shown in Table 2. Please refer to Table 3 for specific results. The F test was used to determine whether the influence of each variable in the regression equation on the response value was significant. The smaller the P value, the more significant the influence of the response variable. For example, a P value less than 0.05 indicates that the variable item has a significant influence on the result, while a value greater than 0.1 indicates that the variable item has no significant influence.

[0057] Table 3 Response surface variance analysis

[0058]

[0059] According to the experimental scheme optimization design and data analysis, the response surface results were analyzed. As shown in Table 3, the F value of the quadratic term model selected in this experiment is 61.69, which is significant (P<0.01). 12 , X 22 and X 32 The corresponding P values ​​are all less than 0.05, indicating that they have a significant impact on the test results. The F value of the lack of fit term is 2.45, which is not significant, indicating that the model is reliable. The multiple correlation coefficient R2 is 0.9875, which indicates that 98.75% of the change in hydrolysis degree comes from the selected variables. The two values ​​of AdjR-Squared and Pred R-Squared (RAdj2-RPred2<0.2) are high and close, which can fully explain the process, so the optimal hydrolysis conditions can be determined. In addition, the signal-to-noise ratio of this experiment is 29.9079, which is significantly higher than 4, which further demonstrates the reliability of the experimental model and can effectively reflect the relationship between the ABTS free radical scavenging rate and pH value, enzyme addition and reaction time. According to the results in Table 3, within the selected factor level range, it can be seen that the order of influence of each variable on the experimental results is: pH> enzyme addition> time.

[0060] By setting a variable value fixed, the effects of the other two variables on the ABTS free radical scavenging rate were studied, and the response surface diagram was drawn ( Figure 6-Figure 8 ). The experimental results show that pH value, enzyme addition and reaction time have an effect on the scavenging rate of ABTS free radicals. With the change of variables, the scavenging rate of ABTS free radicals shows a trend of first rising and then falling. The elliptical contour lines in the figure indicate that there is a significant interaction between the variables. The experimental results show that the interaction effect between pH value and enzyme addition is the most significant. Response surface analysis shows that the model has high accuracy in predicting the degree of hydrolysis and the significant interaction between the two combined variables. Through the analysis of Design-Expert11 statistical software, it can be seen that the optimal process parameters of neutral protease in the process of enzymatic hydrolysis of buffalo milk whey protein are: enzyme addition amount 6299U / g, pH value 7.5, and enzymatic hydrolysis time 2.0h. According to experimental predictions, the removal rate of ABTS free radicals can reach 90.55%. The verification test results show that the removal rate of ABTS free radicals by sample BWH is 90.37%, which is close to the predicted value.

[0061] Embodiment 2:

[0062] This example is a study on the digestion characteristics of BWH based on peptide omics and bioinformatics. The specific method is as follows:

[0063] 1. Preparation of BW (buffalo colostrum whey protein): colostrum was collected from buffalo farms within 1 to 3 days after calving, 1M HCl solution was added to the colostrum to adjust the pH to 4.6, and the colostrum was centrifuged at 8000 r / min and 4°C for 20 min to discard casein, fat and debris, and the supernatant (whey protein solution) was adjusted to pH 7.0 with 1M NaOH solution. After collection, the supernatant was mixed and packaged at low temperature (packaged according to the amount measured each time), and stored at -20°C for later use to obtain BW samples.

[0064] 2. Preparation of BWH (buffalo colostrum whey protein hydrolyzate base): A neutral protease was added to the BW (buffalo colostrum whey protein) prepared in step 1 for single enzyme hydrolysis, wherein the enzyme addition amount was 6299 U / g, the pH value was 7.5, the hydrolysis time was 2.0 h, and the hydrolysis temperature was 50° C. to obtain a BWH sample.

[0065] 3. BW-H (buffalo colostrum whey protein-digestion product): Take 10 mL of the BW (buffalo colostrum whey protein) solution prepared in step 1 and add 8 mL of artificial gastric juice (SGF) stock solution, adjust the pH value of the solution to 3.0 with 1.0 mol / L hydrochloric acid (HCl) solution, then add pepsin and 5 mL of 0.3 mol / L calcium chloride solution, and finally add ultrapure water to adjust the system volume to 20 mL, and then put the reaction system in a 37°C constant temperature shaker for incubation for 120 min. Simulate the intestinal digestive system through a simulation experiment: Take 20 mL of gastric food liquid after gastric digestion and add 16 mL of artificial intestinal juice (SIF) stock solution, use 1.0 mol / L sodium hydroxide (NaOH) solution to adjust the pH value of the solution to 7.0, add trypsin, 10 mg / mL of pig bile salt and 20 mL of 0.3 mol / L calcium chloride solution, and finally use ultrapure water to make the system volume 40 mL. The reaction system was then placed in a 37°C constant temperature shaker for incubation for 120 min, and the reaction mixture was treated in a boiling water bath for 10 min to terminate the reaction to obtain BW-H (buffalo colostrum whey protein-digestion product). The formula of the artificial gastrointestinal juice is shown in Table 4.

[0066] Table 4 Artificial gastrointestinal fluid formula

[0067]

[0068] 4. BWH-H (buffalo colostrum whey protein hydrolyzate base-digestion product): refer to the preparation method of step 3, replace the (buffalo colostrum whey protein) solution with the BWH (buffalo colostrum whey protein hydrolyzate base) solution of step 2, and prepare BWH-H (buffalo colostrum whey protein hydrolyzate base-digestion product) by the same method.

[0069] 5. Peptide extraction: Add appropriate amount of 0.25% acetic acid to the BW in step 1, BWH in step 2, BW-H in step 3, and BWH-H in step 4, respectively, shake well and mix, and centrifuge at high speed. Take the supernatant peptide extract, freeze-dry, add appropriate amount of 0.1% TFA to dissolve, pass through a 10K ultrafiltration tube, wash twice with 0.1% TFA, and use C18 StageTip to desalt the filtrate and vacuum dry.

[0070] 6. After drying, the peptide was re-dissolved with 0.1% TFA, and the OD 260The peptide concentrations were determined and LC-MS / MS analysis was performed.

[0071] 7. Use mass spectrometry database retrieval software and protein database for retrieval analysis, and use the online website BIOPEP (https: / / biochemia.uwm.edu.pl / biopep / start_biopep.php) to predict potential bioactive peptides for the detected peptides, and screen out peptides with immunostimulation and immunoregulation; use the online website PeptideRanker (http: / / distilldeep.ucd.ie / PeptideRanker / ) to detect the biological activity of peptides. Among them, the activity score greater than 0.5 is considered to be biologically active, so as to screen out the peptides with the highest biological activity for further study; the screened peptides are pasted to the ToxinPred, Innovagen, and AllergenFP websites to predict toxicity, solubility, and sensitization.

[0072] The results are as follows Figure 9-Figure 24 visible:

[0073] 1. Peptide distribution expression and distribution of different samples:

[0074] Fig. 9 The Venn diagram of peptides of different groups of samples shows the expression of common peptides and unique peptides in different groups. The expression of common peptides and unique peptides in BWH group, BW group, BWH-H group and BW-H group are 1185, 2796, 1191 and 2458 respectively. The details of common peptides and unique peptides are shown in Fig. 9 ; Fig.10The peptide length distribution diagram of the four groups of samples shows that the peptide length of the BWH group is concentrated in 16 amino acids, the peptide length of the BW group is up to 7 amino acids, but the peptide content is more within 30, the BWH-H group is mostly 6 to 14 amino acids, and there are almost no peptides greater than 20 amino acids. The peptide length of the BW-H group is up to 10 amino acids. The length and distribution of peptide molecular weight are related to protein hydrolysis and peptide bond cleavage; peptides with lower molecular weight are easily absorbed by the human body, thereby exerting potential physiological activity; when identifying peptides, first ensure that the identified peptides have at least one set of data in the corresponding sample with 50% zero value data, and then fill the remaining missing values ​​(the filling value is half of the minimum value of all data), and then perform statistical analysis. If the expression difference fold is greater than 2.0 times (up and down regulation) and meets the screening criteria, it is regarded as a significantly differentially expressed peptide. Through the expression difference analysis of the identified peptides, it was found that compared with the BW group, the BWH group had 691 upregulated peptides and 1438 downregulated peptides. Compared with the BWH-H group, the BWH group had 723 upregulated peptides and 520 downregulated peptides. Compared with the BW-H group, the BW group had 1237 upregulated peptides and 1133 downregulated peptides.

[0075] 2. Differential peptides:

[0076] Fig.11 This is a heat map of differential peptide clustering analysis. It can be seen from the figure that the cluster branches of the BWH group and the BWH-H group are similar, which means that the two groups are highly similar, indicating that they are still similar after simulated in vivo digestion, and that BWH has a certain stability after digestion. Compared with the BW-H group, the cluster branches of the BW group are closer to the BWH group and the BWH-H group, indicating that after in vivo digestion, more differential peptides are produced, and the similarity with BWH is low.

[0077] Fig.12 This is a violin plot of sample expression distribution. It can be seen from the figure that the medians of the violin plots in the same group are close to the same horizontal line, indicating that the data are available and have good repeatability. Fig.13 This is a bubble chart of the correlation of the sample table. The correlation coefficient ranges from -1 to 1, <0 is negative correlation, >0 is positive correlation, and the larger the absolute value, the stronger the correlation. It can be seen from the figure that the correlation coefficients of the same group are all greater than 0.82, and many groups are close to 1, indicating that the correlation of the same group is strong and the data is available. Fig.14 The PCA score graph of the samples, each point represents a sample, different colors represent different groups, the closer the sample distance is, the higher the similarity is, the farther the sample distance is, the greater the difference is, each group has a confidence circle, and the samples outside the confidence circle are abnormal samples. It can be seen from the figure that all samples are within the confidence circle, there are no abnormal samples, and the data are all available. The BWH group and the BWH-H group are close, which once again proves that the similarity is high and the stability is good.

[0078] 3.GO analysis:

[0079] Fig.15 This is a GO functional enrichment bubble chart. In order to further screen out the terms that are more important in statistical significance, we will use Fisher's exact test algorithm to perform functional enrichment analysis on the annotation results. The analysis results are expressed as p-values. When the p-value is less than 0.05, it means that the functional enrichment is significant. The smaller the p-value, the more significant the functional enrichment. The following figure shows the top ten most significant enriched terms in the three aspects of biological process (BP), molecular function (MF) and cellular component (CC). The horizontal axis represents the negative logarithmic transformation of the enrichment significance p-value, and the vertical axis represents GOterm. Each circle represents a term, the size of the circle represents the count, and different colors represent different classifications in the three major branches. Fig.15 Compared with BWH, the immune-related biological processes include humoral immune response, complement activation, and immune effector process. The cellular components are mainly the extracellular region and MHC class I protein complex, among which MHC I is the immune ligand and the molecular function is xanthine dehydrogenase activity, etc. Fig.16 Compared with BWH and BWH-H, the results are similar to A. Fig.17 Compared with BW-H, the immune-related biological processes include humoral immune response, complement activation, immune effector process, positive regulation of immune system process, positive regulation of immune response, and immune response activation. The cell components are mainly extracellular regions, protein-DNA complexes, nucleosomes, DNA packaging complexes, chromosomes, and chromatin. The molecular functions are xanthine dehydrogenase activity, etc. MHC class I molecules bind to endogenous antigen peptides derived from cells, and they play a role in presenting exogenous antigens. When the immune peptide enters the body, it combines with MHC to form a complex, which is recognized by T cells and presented to CD4 + T cells and initiate immune response reactions, such as macrophage phagocytosis. Functional verification of in vitro cell tests and peptide group analysis show that BWH can enhance the body's immunity by enhancing the phagocytic activity of macrophages.

[0080] 4. KEGG pathway analysis:

[0081] Toll receptor is a key innate immune recognition receptor that can trigger intracellular signal transduction and release inflammatory mediators by recognizing common and highly conserved pathogen-associated molecular patterns on the surface of various pathogens, thereby activating the body's immune function. Fig.18 For BWH compared with BW, the KEGG pathways related to immunity included Toll receptor signaling pathway and hematopoietic cell lineage. Fig.19 Compared with BWH-H, the KEGG pathways related to immunity were also Toll receptor signaling pathway and hematopoietic cell lineage. Fig. 20Compared with BW-H, the KEGG pathways related to immunity include Toll receptor signaling pathway and the formation of neutrophil extracellular traps. Hematopoietic cells in the blood participate in immune regulation through specific receptors (such as Toll-like receptors). According to the results of KEGG pathway analysis, this receptor can promote immune cells to release immune signals (such as NO, proinflammatory factors, etc.), thereby regulating the body's immune response and playing an immune enhancement role. Through peptidomics analysis, the influence of receptors on related mechanisms in the immune regulation process can be verified.

[0082] V. Protein binding and interaction analysis:

[0083] The proteins with high connectivity were all precursor proteins of peptides highly expressed in the BWH group. Fig.21 Compared with BWH, the precursor proteins of the top 20 highly expressed peptides in the BWH group included A0A6B9M177 and P02755 in the protein interaction network, among which A0A6B9M177 interacted with 9 proteins and P02755 interacted with 7 proteins. Fig. 22 Compared with BWH and BWH-H, the precursor proteins of the top 20 highly expressed peptides in the BWH group included A0A6B9M177 and P02755 in the protein interaction network, among which A0A6B9M177 interacted with 9 proteins and P02755 interacted with 8 proteins. Fig.23 Compared with BW-H, the precursor proteins of the top 20 highly expressed peptides in the protein interaction network include P02755, among which P02755 interacts with 6 proteins.

[0084] VI. Prediction of potential functions of bioactive peptides:

[0085] PeptideRanker software was used to predict the biological activity of the immune peptides screened from the BWH group. The PR value (PeptideRanker value) represents the predicted biological activity. When the PR value is greater than 0.5, it means that the peptide has biological activity. The higher the value, the stronger the biological activity. Fig.24 It can be seen that among the 140 immune peptides, 64 have a PR value > 0.5, accounting for 45.71%. Among the top 10 peptides with the highest expression, 3 (LVYPFPGPIPKSLPQNIPP, LVYPFPGPIPK, VYPFPGPIPK) have a PR value > 0.5, and the highest PR value is 0.9 (YPFPGPIP, IIGGFLDAKGSFPW), with expression levels of 1155500000 and 3355333 respectively. The peptide expression levels are also relatively high. These five peptides are predicted for potential toxicity, sensitization, and solubility.

[0086] Table 5 Prediction of physicochemical information of immune peptides

[0087]

[0088] Embodiment 3:

[0089] According to the conditions of Example 1, a whey protein active peptide base material and fermented milk were prepared, and the specific process was as follows:

[0090] (1) Preparation of buffalo colostrum-derived active peptides: The amino acid sequence of the immune peptide in Table 5 was submitted to a technology company, and the company was commissioned to use a solid phase chemical synthesis method to synthesize a crude antimicrobial peptide, which was purified by high performance liquid chromatography, then concentrated by a freeze dryer, and finally identified by a mass spectrometer. After qualified identification, the corresponding peptide segments were prepared with high purity, and then mixed in equal mass ratios to obtain buffalo colostrum-derived active peptides.

[0091] (2) Preparation of whey protein active peptide base

[0092] ① The pH value of buffalo colostrum is adjusted to (4.6±0.2), and centrifuged at (4±1)℃ and 5000±500r / min for 20min to remove the upper fat and lower precipitate to obtain buffalo colostrum whey protein solution;

[0093] ② After adjusting the pH value of the enzymatic hydrolyzate buffalo colostrum whey protein solution obtained in step ① to 7.5, preheat it for 8 to 10 minutes, add 6299U / g neutral protease and perform constant temperature enzymolysis for 2.0 hours to obtain an enzymatic hydrolyzate;

[0094] ③ Centrifuge the enzymatic hydrolyzate of step ② at 8000±500r / min for 15±2min, take the supernatant, adjust the pH to neutral, and then add 10% by weight of the buffalo colostrum milk-derived active peptides of step (1) to obtain a whey protein active peptide base material;

[0095] (3) preparing raw buffalo skim milk;

[0096] ① taking raw buffalo milk as raw milk, and then performing skimming treatment to obtain skimmed milk, and controlling the protein content of the skimmed milk to be ≥4.0g / 100g;

[0097] (4) preparing and modulating buffalo milk;

[0098] ① mixing the whey protein active peptide base material obtained in step (2) with the skimmed buffalo milk obtained in step (3), wherein the amount of the whey protein peptide base material added accounts for 5%, 10%, 15% or 20% of the mixed material;

[0099] ② The mixed material obtained in step ① is mixed with white sugar and α-cyclodextrin to obtain modulated buffalo milk, and after being evenly mixed, the mixture is sterilized at 90-100° C. for 10 min to obtain the modulated buffalo milk.

[0100] In this process, 1M food-grade sodium hydroxide solution or 1M citric acid solution is used to adjust the pH value; neutral protease is purchased from Shanghai MacLean Biochemical Technology Co., Ltd., and the enzyme activity is 50U / mg.

[0101] Finally, the ABTS free radical scavenging rate, reducing ability, macrophage proliferation rate, and macrophage NO release of the modulated buffalo milk with different whey protein peptide base addition amounts were tested as shown in Table 6:

[0102] Table 6 Effects of different whey protein peptide base additions on the antioxidant and immune activity of buffalo milk

[0103]

[0104] As can be seen from Table 6, the four indicators of ABTS free radical scavenging rate of antioxidant property, macrophage proliferation rate of reducing ability and immune activity, and macrophage NO release were used to screen the amount of whey protein peptide base material added in buffalo milk, and the optimal addition amount was finally determined to be 15%.

[0105] The amount of added white sugar in step ② was 2%, 3%, and 4%, and the amount of α-cyclodextrin was 0.1%, 0.2%, and 0.3%. The sensory evaluation of the final modulated buffalo milk is shown in Table 7:

[0106] Table 7 Sensory evaluation analysis table of buffalo milk formula

[0107]

[0108] As shown in Table 7, the sensory evaluation scores obtained by analyzing each formula show that the highest scoring formula is 2% white sugar and 0.2% α-cyclodextrin. The verification test shows that the modulated milk with this formula has a reasonable appearance and color, a symmetrical overall shape, a pleasant fragrance, a moderate sweetness, and a harmonious and rich taste.

[0109] Embodiment 4:

[0110] This embodiment optimizes the preparation method of buffalo colostrum whey protein peptide fermented milk, which is characterized by comprising the following steps in sequence:

[0111] 1. Experimental steps of the experimental group:

[0112] (1) Preparation of buffalo colostrum-derived active peptides: The amino acid sequence of the immune peptide in Table 5 is submitted to a technology company, and the company is commissioned to use a solid phase chemical synthesis method to synthesize a crude antimicrobial peptide, which is then purified by high performance liquid chromatography and then concentrated by a freeze dryer. Finally, a mass spectrometer is used for mass spectrometry identification. After qualified identification, the corresponding peptide segments are prepared with high purity, and then the five peptide segments in Table 5 are mixed at the same mass ratio to obtain buffalo colostrum-derived active peptides.

[0113] (2) Preparation of whey protein active peptide base

[0114] ① The pH value of buffalo colostrum is adjusted to (4.6±0.2), and centrifuged at (4±1)℃ and 5000±500r / min for 20min to remove the upper fat and lower precipitate to obtain buffalo colostrum whey protein solution;

[0115] ② After adjusting the pH value of the enzymatic hydrolyzate buffalo colostrum whey protein solution obtained in step ① to 7.5, preheat it for 8 to 10 minutes, add 6299U / g neutral protease and perform constant temperature enzymolysis for 2.0 hours to obtain an enzymatic hydrolyzate;

[0116] ③ Centrifuge the enzymatic hydrolyzate of step ② at 8000±500r / min for 15±2min, take the supernatant, adjust the pH to neutral, and then add 10% by weight of the buffalo colostrum milk-derived active peptides of step (1) to obtain a whey protein active peptide base material;

[0117] (3) preparing raw buffalo skim milk;

[0118] ① taking raw buffalo milk as raw milk, and then performing skimming treatment to obtain skimmed milk, and controlling the protein content of the skimmed milk to be ≥4.0g / 100g;

[0119] (4) preparing fermented buffalo milk;

[0120] ① taking raw buffalo milk as raw milk, and then performing skimming treatment to obtain skimmed milk, and controlling the protein content of the skimmed milk to be ≥4.0g / 100g;

[0121] ② The skimmed buffalo milk obtained in step ① is mixed with the whey protein peptide base material obtained in step (2) and white granulated sugar, and then sterilized at 90-100° C. for 10 min, wherein the amount of the whey protein peptide base material added accounts for 5-20% of the mixed material, and the amount of the white granulated sugar added accounts for 6% of the mixed material;

[0122] ③ Add fermentation bacteria to the mixed material obtained in step ② above, and ferment at a constant temperature of 39-43° C., stop fermenting when whey is slightly precipitated from the fermented milk, and post-ripen at 4° C. for 24 hours to obtain fermented buffalo milk.

[0123] Wherein, the amount of whey protein peptide base material added in step ② of preparing fermented buffalo milk accounts for 15% of the mixed material. In step ③ of preparing fermented buffalo milk, the inoculation amount of the strain is 0.004% of the mass of the skim milk. A 1M food-grade sodium hydroxide solution or a 1M citric acid solution is used to adjust the pH value; in the present invention, the neutral protease can be purchased from Shanghai MacLean Biochemical Technology Co., Ltd., and the enzyme activity is 50U / mg.

[0124] 2. Comparative experiment:

[0125] The control group 1 is different from the experimental group in that the whey protein peptide base material is replaced with a conventional whey protein peptide base material, that is, the buffalo colostrum milk-derived active peptides in step (1) are not added.

[0126] The control group 2 was different from the experimental group in that only fermented buffalo milk was used without adding the whey protein active peptide base material of step (2).

[0127] The antioxidant activity and immune activity of the modulated buffalo milk and fermented buffalo milk obtained from the experimental groups of Example 3 and Example 4 and the control groups 1 and 2 were tested. The specific results are shown in Table 8.

[0128] Table 8 Effects of modulated buffalo milk, fermented buffalo milk and their control on antioxidant activity and immune activity

[0129]

[0130] As shown in Table 8, compared with the control group, the ABTS free radical scavenging rate and reducing capacity of the antioxidant activity test of the modulated buffalo milk and fermented buffalo milk were significantly improved. The indicators of the immune activity test of the modulated buffalo milk and fermented buffalo milk were higher than those of the control group, among which the cell proliferation rate of the modulated buffalo milk, the cell proliferation rate of the fermented buffalo milk, the NO release and the secretion of pro-inflammatory factors were significantly increased compared with the control group.

[0131] In summary, the modulated buffalo milk and fermented buffalo milk obtained by the present invention have the technical advantages of high antioxidant properties and good immune function, and the modulated milk and fermented milk of this formula have reasonable appearance and color, symmetrical overall shape, emit a pleasant fragrance, have just the right sweetness, and have a harmonious and rich taste, which provides a more comprehensive theoretical reference for further research on whey protein.

[0132] The above examples only express several embodiments of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the present invention. It should be pointed out that, for those of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the attached claims.

Claims

1. A buffalo colostrum milk-derived active peptide, characterized in that: The amino acid sequence of the milk-derived active peptide is shown as SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, SEQ ID NO.4 and / or SEQ ID NO.

5.

2. A method for preparing the buffalo colostrum milk-derived active peptide as claimed in claim 1, characterized in that: The method comprises the following steps: (1) Preparation of buffalo colostrum whey protein (BW), preparation of buffalo colostrum whey protein enzymatic hydrolysis base (BWH), preparation of buffalo colostrum whey protein-digestion product (BW-H) and buffalo colostrum whey protein enzymatic hydrolysis base-digestion product (BWH-H) (2) Peptide extraction: add appropriate amount of acetic acid to the BW, BWH, BW-H and BWH-H samples of step (1), shake well to mix, and centrifuge at high speed; take the supernatant peptide extract, freeze-dry, add TFA to dissolve, pass through a 10K ultrafiltration tube, wash twice with 0.1% TFA, and desalt the filtrate using C18 StageTip and dry under vacuum; (3) After drying, the peptide was re-dissolved with TFA and OD 260 Determine peptide concentrations and perform LC-MS / MS analysis; (4) Using mass spectrometry database retrieval software and protein database for retrieval analysis, and using the online website BIOPEP to predict potential bioactive peptides for the detected peptides, and screening out peptides with immunostimulatory and immunoregulatory properties; using the online website PeptideRanker to detect the biological activity of the peptides, where an activity score greater than 0.5 is considered to have biological activity, and the top 10 peptides with the highest expression and a PR value greater than 0.5 are selected; and the screened peptides are pasted to the ToxinPred, Innovagen, and AllergenFP websites respectively to predict toxicity, solubility, and sensitization to obtain the milk-derived active peptides.

3. A method for preparing a formulated milk using the buffalo colostrum milk-derived active peptide according to claim 1 or the buffalo colostrum milk-derived active peptide prepared by the method according to claim 2, characterized in that: The method comprises the following steps: (1) Preparing a whey protein active peptide base material: adjusting the pH value of buffalo colostrum and centrifuging it to remove the upper fat layer and the lower precipitate to obtain a buffalo colostrum whey protein solution; adjusting the pH value of the buffalo colostrum whey protein solution to 7.5, adding an enzyme for enzymolysis to obtain an enzymolysis solution; centrifuging the enzymolysis solution, taking the supernatant, adjusting the pH to neutral, and then adding the buffalo colostrum milk-derived active peptide to obtain the corresponding buffalo colostrum milk-derived active peptide base material; (2) preparing raw buffalo skim milk: taking raw buffalo milk as raw milk, and then performing a skim treatment to obtain skim milk; (3) Preparing modulated buffalo milk: mixing the whey protein active peptide base obtained in step (1) with the defatted buffalo milk obtained in step (2), and uniformly mixing the resulting mixture with white sugar and α-cyclodextrin, followed by sterilization to obtain modulated buffalo milk.

4. A method for preparing fermented milk using the buffalo colostrum milk-derived active peptide according to claim 1 or the buffalo colostrum milk-derived active peptide prepared by the method according to claim 2, characterized in that: The method comprises the following steps: (1) preparing a whey protein active peptide base material: enzymatically hydrolyzing buffalo colostrum, centrifuging, taking the supernatant, adjusting the pH to neutral, and then adding the buffalo colostrum milk-derived active peptide to obtain the corresponding buffalo colostrum milk-derived active peptide base material; (2) Preparing fermented buffalo milk: taking raw buffalo milk as raw milk, and then skimming it to obtain skimmed milk, controlling the protein content of the skimmed milk to be ≥4.0 g / 100 g; mixing the obtained skimmed buffalo milk with the whey protein peptide base material obtained in the above step (1) and white sugar, and then sterilizing it, and then adding fermentation bacteria to the mixture, and fermenting it at a constant temperature of 39 to 43° C., stopping the fermentation when the fermented milk slightly precipitates whey, and post-ripening it at 4° C. for 24 hours to obtain the fermented buffalo milk.

5. The method according to claim 3 or claim 2, characterized in that: The enzyme used for enzymolysis in step (1) is neutral protease, the enzyme addition amount is 6299 U / g, the pH value is 7.5, the enzymolysis time is 2.0 h, and the enzyme activity is 50 U / mg.